Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Precision Optics Corporation, Inc. (PEYE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.21000.0000 (0.00%)
At close: 11:51AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.2100
Open2.2100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.2100 - 2.2100
52 Week Range1.1600 - 3.0000
Volume4,000
Avg. Volume8,569
Market Cap36.951M
Beta (5Y Monthly)0.48
PE Ratio (TTM)N/A
EPS (TTM)-0.0510
Earnings DateFeb 14, 2022 - Feb 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for PEYE

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PRECISION OPTICS INC(MASS)
    Analyst Report: Viavi Solutions IncViavi Solutions is a provider of both hardware-based and software-based network services. Viavi's core business is network and service enablement, which includes test & measurement, network visibility, service assurance, and related capabilities. Viavi also contains Optical Specialty Products, which after several asset dispositions focuses mainly on currency-authentication solutions. In August 2015, Viavi began trading under the VIAV ticker after spinning off JDSU's former CCOP business into Lumentum Inc.
    Rating
    Fair Value
    Economic Moat
    20 days agoArgus Research
View more
Advertisement
Advertisement